India to Kenya: Ampicillin Export Trade Route
India has recorded 213 verified shipments of Ampicillin exported to Kenya, representing a combined trade value of $7.0M USD. This corridor is served by 35 active Indian exporters, with an average shipment value of $32.8K USD. The leading Indian exporter is SPARSH BIO-TECH PRIVATE LIMITED, which accounts for 29% of total export value with 40 shipments worth $2.0M USD. On the buying side, TO THE ORDER OF ABSA BANK UGANDA is the largest importer in Kenya with $1.6M USD in purchases. The top 3 suppliers — SPARSH BIO-TECH PRIVATE LIMITED, SPARSH BIO-TECH PRIVATE LIMITED , SCOTT EDIL PHARMACIA LIMITED — together control 48% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Kenya Ampicillin corridor is one of India's established pharmaceutical export routes, with 213 shipments documented worth a combined $7.0M USD. The route is dominated by SPARSH BIO-TECH PRIVATE LIMITED, which alone accounts for roughly 29% of all export value, reflecting the consolidated nature of India's ampicillin manufacturing sector.
Across 35 active suppliers, the average shipment value stands at $32.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with ampicillin's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 25.1%, placing it at rank #15 among India's top ampicillin export destinations globally.
On the import side, key buyers of Indian ampicillin in Kenya include TO THE ORDER OF ABSA BANK UGANDA, TO THE ORDER, TO THE ORDER OF ABSA BANK UGANDA and 51 others. TO THE ORDER OF ABSA BANK UGANDA is the single largest importer with 20 shipments valued at $1.6M USD.
